Anja Tiede, Lena Stockhoff, Zhaoli Liu, Hannah Rieland, Jim B. Mauz, Valerie Ohlendorf, Birgit Bremer, Jennifer Witt, Anke Kraft, Markus Cornberg, Jan B. Hinrichs, Bernhard C. Meyer, Heiner Wedemeyer, Cheng-Jian Xu, Christine S. Falk, Benjamin Maasoumy
Clin Mol Hepatol 2025;31(1):240-255. Published online November 21, 2024
Background/Aims Systemic Inflammation (SI) is considered a key mechanism in disease progression and development of complications in decompensated liver cirrhosis. SI is mainly driven by portal hypertension and bacterial translocation. Transjugular intrahepatic portosystemic shunt (TIPS) insertion represents an effective treatment for portal hypertension. This study aims to investigate the impact of TIPS insertion on SI and bacterial translocation.
Methods We prospectively included 59 cirrhotic patients undergoing TIPS insertion. Blood samples were collected at TIPS insertion and follow-up (FU) 1, 3, 6, and 12 months thereafter. At all time points, we performed a comprehensive analysis of SI including 43 soluble inflammatory markers (SIMs), and surrogates of bacterial translocation (sCD14, sCD163). To investigate long-term kinetics of SI, C-reactive protein (CRP) and white blood cells (WBC) were retrospectively analyzed in a cohort of 177 patients up to 3 years after TIPS insertion.
Result s: At TIPS insertion, 30/43 SIMs, sCD14, and sCD163 measured significantly higher in cirrhotic patients compared to healthy controls. By FU6 25 SIMs and sCD14 measured at significantly lower levels compared to baseline. Interestingly, in patients with TIPS indication of refractory ascites, IL-6 decreased to levels documented in earlier stages of cirrhosis. In long-term follow-up, CRP levels significantly decreased after TIPS insertion, which translated into lower mortality in Cox regression analysis (HR 0.968, p=0.042). Notably, patients with residual ascites post-TIPS showed significantly higher CRP and IL-6 levels across all follow-ups compared to patients with resolved ascites.
Conclusions Decreasing portal hypertension via TIPS insertion leads to a significant attenuation of SI and bacterial translocation over time.
Citations
Citations to this article as recorded by
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D Lisa Sandmann, Mathias Jachs, Tammo L. Tergast, Lukas Hartl, Birgit Bremer, Martin A. Kabelitz, Michael Schwarz, Julius F.M. Egge, Lorenz Balcar, Benedikt Silvester Hofer, Christine S. Falk, Albert Friedrich Stättermayer, Markus Cornberg, Michael Trauner, JHEP Reports.2026; 8(1): 101643. CrossRef
Die Darm-Leber-Achse bei Leberzirrhose Tony Bruns, Jonel Trebicka Die Gastroenterologie.2026;[Epub] CrossRef
Der Transjuguläre Intrahepatische Portosystemische Shunt (TIPS): aktuelle und innovative Konzepte Dominik Bettinger, Lukas Sturm, Marlene Reincke, Robert Thimme, Michael Schultheiß Zeitschrift für Gastroenterologie.2026; 64(01): 37. CrossRef
Letter on: ‘Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS’. Authors' Reply Christian Labenz, Martin A. Kabelitz, Simon J. Gairing, Lisa Sandmann, Benjamin Maasoumy Alimentary Pharmacology & Therapeutics.2026;[Epub] CrossRef
Leberzirrhose-assoziierte Immundysfunktion (CAID) Valerie Ohlendorf, Laura Buttler, Benjamin Maasoumy DMW - Deutsche Medizinische Wochenschrift.2026; 151(04): 156. CrossRef
Systemic inflammatory indexes as predictors of 18-month mortality among cirrhotic patients receiving transjugular intrahepatic portosystemic shunt Jie Cheng, Xiaobing Wang, Lihua Zhou, Xiaojia Chen, Nuer Tang, Feng Zhou, Feng Ding, Yuan Yang, Jun Lin, Liping Chen Annals of Medicine.2025;[Epub] CrossRef
Advancing our understanding of recompensated cirrhosis - the new “holy grail” of decompensated cirrhosis Thomas Reiberger, Benjamin Maasoumy Journal of Hepatology.2025; 83(3): 615. CrossRef
Transjugular Intrahepatic Portosystemic Shunt (TIPS) Promotes Wound Healing in Cirrhotic Patients With Post‐Splenectomy Complications Na Han, Xulong Yuan, Zhengcai Liu, Yuanping Xu, Shuqiang Yue, Yongquan Shi, Jun Tie Portal Hypertension & Cirrhosis.2025; 4(3): 189. CrossRef
TIPSEMS‐VB Trial Reappraised: Infection Control, HE Prophylaxis, and Ischemic Hepatitis Considerations Kaiyu Bian, Yujie Zhang, Xiang Ma Liver International.2025;[Epub] CrossRef
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation Lucie Simonis, Lorenz Balcar, Anna Schedlbauer, Marta Tonon, Nikolaj Torp, Valeria Santori, Katharina Stopfer, Jan Embacher, Christian Sebesta, Leonie Hafner, Benedikt Silvester Hofer, Nina Dominik, Georg Kramer, Paul Thöne, Michael Trauner, Aleksander Kr Alimentary Pharmacology & Therapeutics.2025; 62(11-12): 1202. CrossRef
Reply Martin A. Kabelitz, Lisa Sandmann, Benjamin Maasoumy Clinical Gastroenterology and Hepatology.2025;[Epub] CrossRef
Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Anja Tiede, Benjamin Maasoumy Alimentary Pharmacology & Therapeutics.2025; 62(11-12): 1230. CrossRef
Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Authors' Reply Lucie Simonis, Lorenz Balcar, Georg Kramer, Thomas Reiberger, Georg Semmler Alimentary Pharmacology & Therapeutics.2025; 62(11-12): 1233. CrossRef
Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary center Marlene Hintersteininger, Julia Kappel, Theresa Müllner-Buscics, Susanna Riegler, Nina Dominik, Georg Kramer, Christian Sebesta, Paul Thöne, Albert Friedrich Stättermayer, Lukas Reider, Maria Schoder, Catharina Klausenitz, Raoul Varga, Fredrik Waneck, Mic Wiener klinische Wochenschrift.2025;[Epub] CrossRef
Prävention der Dekompensation bei einer fortgeschrittenen Lebererkrankung Marlene Reincke, Lukas Sturm, Robert Thimme, Dominik Bettinger DMW - Deutsche Medizinische Wochenschrift.2025; 150(21): 1267. CrossRef
Neurofilament Light Chains in Serum Predict Post—Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy Christian Labenz, Eva Maria Schleicher, Myriam Meineck, Martin A. Kabelitz, Alena F. Ehrenbauer, Anja Tiede, Jim B. Mauz, Sven Danneberg, Michael Bernhard Pitton, Falk Steffen, Julia Weinmann‐Menke, Peter Robert Galle, Stefan Bittner, Felix Lüssi, Jens Uw MedComm.2025;[Epub] CrossRef
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis Andrea Kornfehl, Anja Tiede, Paul Hemetsberger, Julia Kappel, Theresa Müllner-Bucsics, Lena Stockhoff, Hannah Rieland, Lukas Reider, Nina Dominik, Georg Kramer, Michael Trauner, Mattias Mandorfer, Christine Falk, Benjamin Maasoumy, Thomas Reiberger, Lukas JHEP Reports.2024; : 101308. CrossRef
First
Prev
